BAX

#928
Baxter International Inc. Common Stock
18.9 1 USD
-1.72%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
18.89
19.18
Range Annuel
15.73
32.04
Changement quotidien
-1.72%
Changement Mensuel
+6.66%
Evolution sur 6 mois
+1.94%
Changement Annuel
-37.82%
Clôture Précédente
19.2 4
Open
19.1 5
Low
18.8 9
High
19.1 8
Volume
532
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 9.77 B
  • Employee 38 K
  • Founded N/A
  • CEO Andrew Hider
  • Website www.baxter.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCVJ77
  • Industry Instruments et Fournitures Médicales
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.22
ratio cours/chiffre d'affaires
0.87
Dividende par action
0.52
Rendement du dividende (%)
2.72

Baxter International Inc. Common Stock

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

Nouvelles